Tissue dissociation and homogenization are excellent candidates for automation in LC-MS workflows, helping scientists achieve consistent and reproducible protein analysis. Scientists use liquid ...
Mass spec–based methods coupled with chromatography separation techniques are fundamental to success in proteomics research and biopharmaceutical development, and low-flow liquid chromatography has ...
The LC–MS analysis uncovered significant metabolic variations between chronic persistent and acute exacerbation asthma groups, identifying L-carnitine as a highly accurate differential metabolite and ...
Shimadzu Scientific Instruments announces the release of the Nexera MX ultra-high speed LCMS system for multiplex analysis. Equipped with Nexera MX Dual Stream Technology (MX-DST), the system can ...
Synthetic oligonucleotides have been used as critical research reagents in the biotechnology industry since its beginning in the 1970s. Their increasing use first led to the formation of many core ...
Relationship between immune-inflammatory markers and clinical features and deepness of tumor response and prognosis of patients with PD-L1 ≥50% metastatic NSCLC receiving first-line immunotherapy.
Monoclonal antibodies (mAbs) are complex biotherapeutic proteins, commonly generated in a mammalian cell line to attain adequate yield and, importantly, to decorate the antibody with essential ...
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) today introduced the BioAccord™ System, a purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution that will expand ...
Researchers used LC-MS/MS to analyze 52 sake samples from Japan for neonicotinoids and other insecticides. 88% contained detectable insecticides, with dinotefuran being the most common. Contamination ...
Shimadzu Scientific Instruments (SSI) announces the release of the Micro-ESI 9030, an interface compatible with the Nexera Mikros Microflow LCMS that enables micro flowrate analysis with the LCMS-9030 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results